Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2024-03-25
2024-04-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Egg-Banking and Ovo-donation
NCT00785993
Does Preimplantation Genetic Diagnosis for Sex Selection Affect the Pregnancy and Miscarriage Rates in Women With an Expected Good Ovarian Response Undergoing IVF/ICSI Cycles?
NCT02149251
Retrospective Database Studies
NCT01219296
Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening
NCT03173885
Preimplantation Genetic Screening in Women Over 35 Year
NCT00593671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: Investigate the rate of new information obtained at GRA which was not included in the full application, as follows:
* New information with no change to health risk assessment (i.e. change in number of relatives)
* New information with a change to health risk assessment (i.e. known or suspected diagnoses for OD or family), with one of the following decisions
* Still acceptable/approved for clinic (ie new multifactorial condition reported, such as diabetes)
* Decline based on TPN internal guidelines alone (ie meets NCCN criteria for genetic testing)
* Decline based on ASRM guidelines (ie first degree relative with a major malformation)
Hypothesis: Information obtained through GRA with a certified genetic counselor will lead to more detailed and accurate assessment of donor applicant eligibility. Some information obtained through GRA, which was not apparent on application, will lead to a donor applicant being declined based on internal Prelude Network Donor Screening Guidelines and/or guidelines set forth by the American Society of Reproductive Medicine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GeneScreen Counseling, LLC
UNKNOWN
Inception Fertility Research Institute, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Inception Fertility LLC
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INC-GS-2024-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.